Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women
- PMID: 2849489
Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women
Abstract
Serum concentrations of vitamin D metabolites were measured in 19 healthy premenopausal women before and during treatment with 4000 IU per day of either vitamin D2 or vitamin D3 for 8 weeks. Vitamin D2 treatment increased the serum concentration of 25(OH)D2, but a corresponding decrease in 25(OH)D3 resulted in an unchanged value for total 25(OH)D. The serum concentration of the D3 dihydroxy metabolites was also significantly decreased. Vitamin D3 treatment increased the serum concentrations of 25(OH)D3 and D3 dihydroxy metabolites. The serum concentration of 1,25(OH)2D did not change in either of the treatment groups. We conclude that vitamin D2 and vitamin D3 given in the same doses in international units have a different effect on the serum concentration of vitamin D metabolites and biochemical indices of calcium metabolism.
Similar articles
-
The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.Scand J Rheumatol. 2009 Mar-Apr;38(2):149-53. doi: 10.1080/03009740802419081. Scand J Rheumatol. 2009. PMID: 18991184 Clinical Trial.
-
Selective monitoring of vitamin D2 and D3 supplementation with a highly specific 25-hydroxyvitamin D3 immunoassay with negligible cross-reactivity to 25-hydroxyvitamin D2.Clin Chim Acta. 2009 Jun 27;404(2):144-8. doi: 10.1016/j.cca.2009.03.043. Epub 2009 Mar 29. Clin Chim Acta. 2009. PMID: 19336231
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.Bone. 2013 Oct;56(2):271-5. doi: 10.1016/j.bone.2013.06.012. Epub 2013 Jun 20. Bone. 2013. PMID: 23792937 Clinical Trial.
-
Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.Rheum Dis Clin North Am. 1994 Aug;20(3):759-75. Rheum Dis Clin North Am. 1994. PMID: 7984788 Review.
Cited by
-
A comparison of the effects of alfacalcidol treatment and vitamin D2 supplementation on calcium absorption in elderly women with vertebral fractures.Osteoporos Int. 1996;6(4):284-90. doi: 10.1007/BF01623386. Osteoporos Int. 1996. PMID: 8883116 Clinical Trial.
-
Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis.Am J Clin Nutr. 2012 Jun;95(6):1357-64. doi: 10.3945/ajcn.111.031070. Epub 2012 May 2. Am J Clin Nutr. 2012. PMID: 22552031 Free PMC article.
-
Differential effects of vitamin D2 and D3 supplements on 25-hydroxyvitamin D level are dose, sex, and time dependent: a randomized controlled trial.BMC Endocr Disord. 2017 Feb 24;17(1):12. doi: 10.1186/s12902-017-0163-9. BMC Endocr Disord. 2017. PMID: 28231782 Free PMC article. Clinical Trial.
-
Vitamin D and Gestational Diabetes Mellitus: Is There a Link?Antioxidants (Basel). 2019 Oct 25;8(11):511. doi: 10.3390/antiox8110511. Antioxidants (Basel). 2019. PMID: 31731439 Free PMC article. Review.
-
Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults.J Clin Endocrinol Metab. 2011 Apr;96(4):981-8. doi: 10.1210/jc.2010-0015. Epub 2011 Feb 2. J Clin Endocrinol Metab. 2011. PMID: 21289249 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical